NCT06475105View on ClinicalTrials.gov

Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes

PHASE4RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Decompensated Heart Failure
Interventions
DRUG

Oral Acetazolamide

Participants will be randomized into group receiving either oral acetazolamide or placebo for up to 3 days

DRUG

Placebo

Participants will be randomized into group receiving either oral acetazolamide or placebo for up to 3 days

Trial Locations (2)

50244

RECRUITING

Department of Cardiology and Vascular Medicine, Universitas Diponegoro, Kariadi Central General Hospital, Semarang

RECRUITING

Kariadi Central General Hospital, Semarang

All Listed Sponsors
lead

Universitas Diponegoro

OTHER